Another important issue is the potential relationship between serum sTREM2 levels, metabolic markers, and biomarkers involved in neurodegenerative diseases, such as the amyloid-β42/amyloid-β40 ratios, p-tau181 levels, and levels of the neurofilament light chain. This evidence concerns the gene NEFL and neurodegenerative disease.